These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29289523)

  • 1. Principles and approaches to the treatment of immune-mediated movement disorders.
    Mohammad SS; Dale RC
    Eur J Paediatr Neurol; 2018 Mar; 22(2):292-300. PubMed ID: 29289523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibody-associated movement disorders.
    Mohammad SS; Ramanathan S; Brilot F; Dale RC
    Neuropediatrics; 2013 Dec; 44(6):336-45. PubMed ID: 24203856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Movement disorders in paraneoplastic and autoimmune disease.
    Panzer J; Dalmau J
    Curr Opin Neurol; 2011 Aug; 24(4):346-53. PubMed ID: 21577108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune Movement Disorders: a Clinical and Laboratory Approach.
    Honorat JA; McKeon A
    Curr Neurol Neurosci Rep; 2017 Jan; 17(1):4. PubMed ID: 28120141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraneoplastic autoimmune movement disorders.
    Lim TT
    Parkinsonism Relat Disord; 2017 Nov; 44():106-109. PubMed ID: 29097081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study of acute movement disorders in children.
    Dale RC; Singh H; Troedson C; Pillai S; Gaikiwari S; Kozlowska K
    Dev Med Child Neurol; 2010 Aug; 52(8):739-48. PubMed ID: 20163436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune movement disorders.
    Mckeon A; Vincent A
    Handb Clin Neurol; 2016; 133():301-15. PubMed ID: 27112684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune and paraneoplastic movement disorders: An update.
    Baizabal-Carvallo JF; Jankovic J
    J Neurol Sci; 2018 Feb; 385():175-184. PubMed ID: 29406902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Movement disorder emergencies in childhood.
    Kirkham FJ; Haywood P; Kashyape P; Borbone J; Lording A; Pryde K; Cox M; Keslake J; Smith M; Cuthbertson L; Murugan V; Mackie S; Thomas NH; Whitney A; Forrest KM; Parker A; Forsyth R; Kipps CM
    Eur J Paediatr Neurol; 2011 Sep; 15(5):390-404. PubMed ID: 21835657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraneoplastic movement disorders.
    Popławska-Domaszewicz K; Florczak-Wyspiańska J; Kozubski W; Michalak S
    Rev Neurosci; 2018 Sep; 29(7):745-755. PubMed ID: 29561731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-methyl-D-aspartate receptor antibody-associated movement disorder without encephalopathy.
    Hacohen Y; Dlamini N; Hedderly T; Hughes E; Woods M; Vincent A; Lim M
    Dev Med Child Neurol; 2014 Feb; 56(2):190-3. PubMed ID: 24127856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Movement disorders in autoimmune diseases.
    Baizabal-Carvallo JF; Jankovic J
    Mov Disord; 2012 Jul; 27(8):935-46. PubMed ID: 22555904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraneoplastic movement disorders.
    Mehta SH; Morgan JC; Sethi KD
    Curr Neurol Neurosci Rep; 2009 Jul; 9(4):285-91. PubMed ID: 19515280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune-mediated extrapyramidal movement disorders, including Sydenham chorea.
    Dale RC
    Handb Clin Neurol; 2013; 112():1235-41. PubMed ID: 23622334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune Movement Disorders: A Video-Based Case Series of 11 Patients.
    Chouksey A; Pandey S
    Eur Neurol; 2021; 84(2):124-128. PubMed ID: 33752203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune basal ganglia disorders.
    Dale RC; Brilot F
    J Child Neurol; 2012 Nov; 27(11):1470-81. PubMed ID: 22832771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraneoplastic movement disorders.
    McKeon A; Tracy J
    Handb Clin Neurol; 2024; 200():211-227. PubMed ID: 38494279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune Movement Disorders.
    Fearon C; O'Toole O
    Semin Neurol; 2018 Jun; 38(3):316-329. PubMed ID: 30011412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical features, underlying immunology, and treatment of autoantibody-mediated movement disorders.
    Damato V; Balint B; Kienzler AK; Irani SR
    Mov Disord; 2018 Sep; 33(9):1376-1389. PubMed ID: 30218501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Movement disorders in children with anti-NMDAR encephalitis and other autoimmune encephalopathies.
    Mohammad SS; Fung VS; Grattan-Smith P; Gill D; Pillai S; Ramanathan S; Brilot F; Dale RC
    Mov Disord; 2014 Oct; 29(12):1539-42. PubMed ID: 25154478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.